Izon Science

Izon Science enables nanoparticle researchers across a range of disciplines to isolate and characterise particles with precision. With the field of extracellular vesicles (EVs) now pushing towards clinical applications, Izon is meeting the need for scalable EV isolation solutions for EV-based diagnostics and EV-based therapeutics, as well as fundamental EV research. This is achieved through its evolving range of size exclusion chromatography-based qEV columns, associated instrumentation for automating particle isolation, and customised bioprocessing development services. With such diverse customers, the qEV platform accommodates a broad range of sample types and volumes. Meanwhile, Izon brings high-resolution insights to the physical characterisation...

Particle characterization,drug delivery particle analysis,exosome and microparticle analysis,virus and vaccine particle analysis,extracellular vesicle isolation,virus isolation,exosome processing,nanoparticle analysis,exosome isolation,nanoparticle measurement,size exclusion chromatography,rna extraction,extracellular vesicle characterisation,extracellular vesicle analysis,lipid nanoparticles,and tunable resistive pulse sensing

Izon science operates in the Nanotechnology research industry.

Izon science's revenue is 11m - 100m

Izon science has 11 - 50 employees.